Calcium Acetate Tablets(Ref.brand: Phoslo®, Calphron®, And Eliphos®(Us &Eu) Generics 667 mg Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 667 mg

Reference Brands: PhosLo®, Calphron®, and Eliphos®(US &EU)

Calcium Acetate Tablets are phosphate binders used in nephrology to control high blood phosphate levels in chronic kidney disease (CKD) patients on dialysis.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Calcium Acetate Tablets are widely used in nephrology for the effective management of hyperphosphatemia in patients with chronic kidney disease (CKD) undergoing dialysis. As a phosphate binder, calcium acetate reduces phosphate absorption from the gastrointestinal tract, helping prevent complications such as renal osteodystrophy and vascular calcification. This renal care medication is marketed under trusted brand names like PhosLo®, Calphron®, and Eliphos® in the US and EU. Ideal for hospital procurement, dialysis centers, and Pharma B2B distribution, our GMP-compliant Calcium Acetate Tablets are available in bulk supply to meet global sourcing needs for renal pharmaceuticals and CKD treatment solutions,

Calcium Acetate Tablets(Ref.brand: Phoslo®, Calphron®, And Eliphos®(Us &Eu) Generics — third party manufacturing & bulk supply

Calcium Acetate Tablets(Ref.brand: Phoslo®, Calphron®, And Eliphos®(Us &Eu) Generics 667 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Calcium Acetate Tablets(Ref.brand: Phoslo®, Calphron®, And Eliphos®(Us &Eu) Generics is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Calcium Acetate Tablets(Ref.brand: Phoslo®, Calphron®, And Eliphos®(Us &Eu) Generics listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Calcium Acetate Tablets(Ref.brand: Phosl... →

Back to Listing

Frequently Asked Questions

Calcium Acetate Tablets(Ref.Brand: PhosLo®, Calphron®, and Eliphos®(US &EU) Generics is listed as Tablet in 667 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Calcium Acetate Tablets(Ref.Brand: PhosLo®, Calphron®, and Eliphos®(US &EU) Generics is referenced against PhosLo®, Calphron®, and Eliphos®(US &EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.